Shanghai Aladdin Biochemical Technology Co.,Ltd. (SHA:688179)
China · Delayed Price · Currency is CNY 15.87
-1.12 (-6.59%)
Jul 30, 2026, 4:00 PM EDT
SHA:688179 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 736.28 | 695.72 | 533.56 | 402.88 | 378.1 | 287.66 |
Revenue Growth | 30.25% | 30.39% | 32.44% | 6.55% | 31.44% | 22.82% |
Gross Profit Gross Profit Growth | 466.61 | 431.59 | 329.18 | 240.33 | 221.82 | 177.55 |
Operating Income Operating Income Growth | 190.68 | 172.93 | 126.62 | 92.23 | 94.63 | 92.03 |
Net Income Net Income Growth | 106.97 | 102.06 | 98.76 | 85.83 | 92.77 | 89.36 |
Earnings Per Share EPS Growth | 0.32 | 0.31 | 0.29 | 0.28 | 0.27 | 0.27 |
EPS Growth | 3.38% | 6.90% | 2.37% | 5.75% | -0.89% | -4.29% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 710.04 | 890.97 | 508.79 | 575.65 | 622.37 | 399.53 |
Total Debt Total Debt Growth | 790.4 | 773.41 | 442.75 | 358.46 | 341.61 | 12.9 |
Net Cash (Debt) Net Cash Growth | -80.36 | 117.56 | 66.04 | 217.19 | 280.77 | 386.63 |
Net Cash Growth | - | 78.01% | -69.59% | -22.64% | -27.38% | -29.65% |
Net Cash Per Share Net Cash Per Share Growth | -0.24 | 0.36 | 0.19 | 0.72 | 0.81 | 1.17 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 237.05 | 400.57 | 151.52 | 55.79 | -43.26 | 15 |
Capital Expenditures CapEx Growth | -45.51 | -49 | -35.52 | -45.68 | -61.97 | -113.38 |
Free Cash Flow Free Cash Flow Growth | 191.54 | 351.57 | 115.99 | 10.11 | -105.23 | -98.38 |
Free Cash Flow Growth | 33.22% | 203.10% | 1047.62% | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 63.37% | 62.03% | 61.70% | 59.65% | 58.67% | 61.72% |
Operating Margin | 25.90% | 24.86% | 23.73% | 22.89% | 25.03% | 31.99% |
Pretax Margin | 22.11% | 22.14% | 23.92% | 23.56% | 27.95% | 35.36% |
Profit Margin | 14.53% | 14.67% | 18.51% | 21.30% | 24.54% | 31.06% |
FCF Margin | 26.02% | 50.53% | 21.74% | 2.51% | -27.83% | -34.20% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.140 | 0.140 | 0.200 | 0.179 | 0.106 | 0.121 |
Dividend Per Share Growth | -23.63% | -30.00% | 11.98% | 68.02% | -12.51% | -19.96% |
Dividend Yield | 0.82% | 1.13% | 1.77% | 1.63% | 0.73% | 0.54% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 49.52 | 40.55 | 38.76 | 44.23 | 55.06 | 88.80 |
Forward PE | 33.06 | 32.23 | 26.93 | 30.05 | - | - |
P/FCF Ratio | 29.89 | 11.77 | 33.00 | 375.59 | - | - |
PS Ratio | 7.77 | 5.95 | 7.17 | 9.42 | 13.51 | 27.59 |